PROCEPT BioRobotics Corp (NAS:PRCT)

Q3 2025 Procept Biorobotics Corp Earnings Call Transcript

Nov 4, 2025 / 09:30 PM GMT

Release Date Price: $35.02 (+1.48%)

Transcript 10-Q8-K

Key Points

Positve

PROCEPT BioRobotics Corp (PRCT) reported a strong revenue growth of 43% year-over-year for Q3 2025, reaching $83.3 million.
The company saw a significant increase in US procedures, handpiece, and other consumable revenue, which grew by 50% compared to the previous year.
International revenue also showed robust growth, increasing by 53% year-over-year.
The company is implementing initiatives to improve commercial execution and speed up new account launches, showing early positive results.
PROCEPT BioRobotics Corp (PRCT) is expanding its focus internationally and increasing investment in regions that value transformational therapies.

Negative

There is a delay in the realization of utilization benefits for newly installed systems, affecting procedural targets.
The company is facing challenges with the timing of sales and the first procedure, leading to hospitals holding excess hydro handpieces.
Operating expenses increased to $77.2 million in Q3 2025, up from $59.3 million in the same period the previous year.
Despite revenue growth, the company reported a net loss of $21.4 million for Q3 2025.
The company anticipates modest procedural headwinds in the first half of 2026 due to strategic investments and organizational changes.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PRCT.OQ - Procept Biorobotics Corp
Q3 2025 Procept Biorobotics Corp Earnings Call
Nov 04, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to Proce Biorobotics 3rd quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn it over to Matt Pascal, Vice President, Investor Relations, for a few introductory comments.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good afternoon and thank you for joining Procey robotics 3rd quarter of 2025 earnings conference call, presenting on

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.